American Diabetes Association (ADA) 78th Scientific Sessions
American Diabetes Association (ADA) 78th Scientific Sessions
Upon successful registration, you will be able to download an ADA Certificate of Participation
Login button
Upon successful registration, you will be able
to download an ADA Certificate of Participation
Video Highlights
FRIDAY, JUNE 9th
Reaching an International Consensus on Standardizing Continuous Glucose Monitoring (CGM) Outcomes―Aligning Clinicians, Researchers, Patients, and Regulators

Simon R. Heller, FRCP, DM
University of Sheffield

SATURDAY, JUNE 10th
GLP-1s and SGLT2s—To Do or Not to Do in Type 1 Diabetes Mellitus?

Thomas F. Dejgaard, MD
Steno Diabetes Center Copenhagen

SUNDAY, JUNE 11th
Joint ADA/ASN Symposium—Effects of New Diabetic Treatments on Diabetic Kidney Disease

Katherine R. Tuttle, MD, FACP, FASN, FNKF
University of Washington School of Medicine

MONDAY, JUNE 12th
Hepatic Lipid and Glucose Metabolism

Michael Roden, MD – Director
German Diabetes Center (DDZ)
Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf

New Insights into Prevention and Treatment of Hypoglycemia

Candace Reno, PhD
University of Utah

TUESDAY, JUNE 13th
Take-home Messages from 2017 ADA Scientific Sessions

Jane Reusch, MD
ADA President-Elect, Medicine & Science
Professor of Medicine, Biochemistry and Bioengineering and Associate Director of the Center for Women’s Health Research University of Colorado School of Medicine Anschutz Medical Campus

FRIDAY, JUNE 22
Real-World Evidence in Diabetes

Stewart B. Harris, MD
Centre for Studies in Family Medicine Schulich School of Medicine & Dentistry
Western Centre for Public Health & Family Medicine
London, ON, Canada

SATURDAY, JUNE 23
Reframing Exercise―The Surprising Science behind Motivating Patients to Be More Physically Active

Michelle Segar, PhD, MPH
Sport, Health, and Activity Research and Policy Center, University of Michigan
Ann Arbor, MI (USA)

ADA Diabetes Care Symposium―Using Continuous Glucose Monitoring and Smart Devices to Control Glucose when It Matters Most

Jennifer Sherr, MD, PhD
Associate Professor, Pediatrics (Endocrinology) Yale University School of Medicine
One Long Wharf Drive, Suite 503
New Haven, CT (USA)

SUNDAY, JUNE 24
Update on Type 2 Diabetes Clinical Trials

Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research, Associate Medical Director of Research and Education, Florida Hospital Diabetes Institute, Senior Investigator and Diabetes Program Lead, Translational Research Institute for Metabolism and Diabetes
Orlando, FL, (USA)

The Veterans Affairs Diabetes Trial (VADT) at 15 Years

Peter Reaven MD, Division of Endocrinology and Metabolism, Department of Medicine (CS-111E)
Carl T. Hayden Veterans Affairs Medical Centre
Phoenix, AZ (USA)

MONDAY, JUNE 25
Update on Hypoglycemia

Prof. Simon Heller
Professor of Clinical Diabetes
University of Sheffield;
Sheffield, UK

Clinical Trials for Type 1 Diabetes—Current, Emerging, and Novel

Robert Ratner, MD Professor of Medicine, Georgetown University School of Medicine
Washington, DC (USA)

TUESDAY, JUNE 26
Insulin Therapy—To the Future and Back

Carol Wysham, MD
Section Head of the Rockwood Center for Diabetes and Endocrinology
Spokane, WA (USA)

Management of Hyperglycemia in Type 2 Diabetes—Draft ADA/EASD Consensus Report 2018

Deborah Jane Wexler, MD
Associate Clinical Chief, MGH Diabetes Unit, Clinical Director, MGH Diabetes Center
Boston, MA (USA)

JUNE 10TH, 2019
Carolina, results from a major clinical trial

Steven Khan, MD

JUNE 8TH, 2019
Joint ADA/ACC Mini-Symposium – Cardiovascular Disease in Patients with Diabetes?

Darren McGuire, MD

JUNE 9TH, 2019
Once-Weekly Dulaglutide and Major Cardiovascular Events—Results of the REWIND Trial

Vivian Fonseca, MD

JUNE 11TH, 2019
Carmelina, results from a major clinical trial

Steven Khan, MD